Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 4”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02563002
What this trial is testing

Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)

Who this might be right for
Colorectal Carcinoma
Merck Sharp & Dohme LLC 307
Testing effectiveness (Phase 2)Study completedNCT03993353
What this trial is testing

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+9 more
University of California, San Diego 7
Large-scale testing (Phase 3)Study completedNCT02702401
What this trial is testing

Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)

Who this might be right for
Hepatocellular Carcinoma
Merck Sharp & Dohme LLC 413
Not applicableLooking for participantsNCT07219927
What this trial is testing

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Who this might be right for
Parkinson Disease
Supernus Pharmaceuticals, Inc. 120
Not applicableLooking for participantsNCT07790744
What this trial is testing

A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD

Who this might be right for
REM Sleep Behavior DisorderSynucleinopathiesParkinson's Disease (PD)+1 more
Danish Research Centre for Magnetic Resonance 100
Post-approval studies (Phase 4)Study completedNCT05312632
What this trial is testing

Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea

Who this might be right for
Parkinson Disease
Eisai Korea Inc. 201
Early research (Phase 1)UnknownNCT03545815
What this trial is testing

Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.

Who this might be right for
Solid Tumor, Adult
Chinese PLA General Hospital 10
Early research (Phase 1)Study completedNCT02778594
What this trial is testing

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 17
Large-scale testing (Phase 3)Looking for participantsNCT06623422
What this trial is testing

Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 680
Post-approval studies (Phase 4)Study completedNCT00485069
What this trial is testing

REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study

Who this might be right for
Parkinson DiseaseParkinson's Disease
GlaxoSmithKline 123
Large-scale testing (Phase 3)Active Not RecruitingNCT05239741
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 100
Testing effectiveness (Phase 2)UnknownNCT05626569
What this trial is testing

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT02549209
What this trial is testing

Pembro/Carbo/Taxol in Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Daniela Matei, MD 46
Large-scale testing (Phase 3)Study completedNCT02684292
What this trial is testing

Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)

Who this might be right for
Hodgkin Lymphoma
Merck Sharp & Dohme LLC 304
Large-scale testing (Phase 3)Study completedNCT02564263
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 628
Very early researchLooking for participantsNCT06032026
What this trial is testing

Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15

Who this might be right for
Tauopathies
University of Pennsylvania 70
Large-scale testing (Phase 3)Study completedNCT04776148
What this trial is testing

Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)

Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 563
Testing effectiveness (Phase 2)UnknownNCT05392686
What this trial is testing

PD1 and PARP for Maintenance Therapy in NSLLC

Who this might be right for
Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 52
Early research (Phase 1)Study completedNCT01532115
What this trial is testing

Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 64
Large-scale testing (Phase 3)Looking for participantsNCT06989112
What this trial is testing

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial Cancer
AstraZeneca 600
Next Page